Genetic analysis of BRCA1 function in a defined tumor cell line

Molecular Cell

Volumn 4, Issue 6, 1999, Pages 1093-1099

  Scully, Ralph ^a   Ganesan, Shridar ^a   Vlasakova, Katerina ^a   Chen, Junjie ^a,b   Socolovsky, Merav ^c   Livingston, David M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CANCER CELL CULTURE; DNA STRAND BREAKAGE; GAMMA RADIATION; GENE EXPRESSION; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; RADIOSENSITIVITY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

EID: 0033400828     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80238-5     Document Type: Article

References (41)

1. Abbott, D.W., Thompson, M.E., Robinson-Benion, C., Tomlinson, G., Jensen, R.A., and Holt, J.T. (1999). BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J. Biol. Chem. 274, 18808-18812.
2. Badie, C., Iliakis, G., Foray, N., Alsbeih, G., Cedervall, B., et al. (1995). Induction and rejoining of DNA double-strand breaks and interphase chromosome breaks after exposure to X rays in one normal and two hypersensitive human fibroblast cell lines. Radiat. Res. 144, 26-35.
3. Chapman, M.S., and Verma, I.M. (1996). Transcriptional activation by BRCA1. Nature 382, 678-679.
4. Chen, J., Silver, D.P., Walpita, D., Cantor, S.B., Gazdar, A.F., et al. (1998). Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2, 317-328.
5. Connor, F., Bertwistle, D., Mee, P.J., Ross, G.M., Swift, S., et al. (1997). Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat. Genet. 17, 423-430.
6. Cortez, D., Wang, Y., Qin, J., and Elledge, S.J. (1999). Requirement of ATM-dependent phosphorylation of Brca1 in the DNA damage response to double-strand breaks. Science 286, 1162-1166.
7. Cressman, V.L., Backlund, D.C., Hicks, E.M., Gowen, L.C., Godfrey, V., and Koller, B.H. (1999). Mammary tumor formation in p53-and BRCA1-deficient mice. Cell Growth Differ. 10, 1-10.
8. Foray, N., Arlett, C.F., and Malaise, E.P. (1997). Radiation-induced DNA double-strand breaks and the radiosensitivity of human cells: a closer look. Biochimie 79, 567-575.
9. Gowen, L.C., Avrutskaya, A.V., Latour, A.M., Koller, B.H., and Leadon, S.A. (1998). BRCA1 required for transcription-coupled repair of oxidative DNA damage. Science 281, 1009-1012.
10. Hakem, R., de la Pompa, J.L., Sirard, C., Mo, R., Woo, M., et al. (1996). The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85, 1009-1023.
11. Hakem, R., de la Pompa, J.L., Elia, A., Potter, J., and Mak, T.W. (1997). Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation. Nat. Genet. 76, 298-302.
12. Harkin, D.P., Bean, J.M., Miklos, D., Song, Y.H., Truong, V.B., et al. (1999). Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97, 575-586.
13. Hua, X., Liu, X., Ansari, D.O., and Lodish, H.F. (1998). Synergistic cooperation of TFE3 and smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene. Gen. Dev. 12, 3084-3095.
14. Kiltie, A.E., and Ryan, A.J. (1997). SYBR green I staining of pulsed field agarose gels is a sensitive and inexpensive way of quantitating DNA double-strand breaks in mammalian cells. Nucleic Acids Res. 25, 2945-2946.
15. Lu, X., and Lane, D.P. (1993). Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75, 765-778.
16. Ludwig, T., Chapman, D.L., Papaioannou, V.E., and Efstratiadis, A. (1997). Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Gen. Dev. 11, 1226-1241.
17. Monteiro, A.N., August, A., and Hanafusa, H. (1996). Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA 93, 13595-13599.
18. Moynahan, M.E., Chiu, J.W., Koller, B.H., and Jasin, M. (1999). Brca1 controls homology-directed DNA repair. Mol. Cell 4, 511-518.
19. Nevaldine, B., Longo, J.A., King, G.A., Vilenchik, M., Sagerman, R.H., and Hahn, P.J. (1993). Induction and repair of DNA double-strand breaks. Radiat. Res. 133, 370-374.
20. Painter, R.B. (1982). Structural changes in chromatin as the basis for radiosensitivity in ataxia telangiectasia. Cytogenet. Cell Genet. 33, 139-144.
21. Painter, R.B., and Young, B.R. (1980). Radiosensitivity in ataxiatelangiectasia: a new explanation. Proc. Natl. Acad. Sci. USA 77, 7315-7317.
22. Patel, K.J., Yu, V.P.C.C., Lee, H., Corcoran, A., Thistlethwaite, F.C., et al. (1998). Involvement of Brca2 in DNA repair. Mol. Cell 1, 347-357.
23. Scully, R., Ganesan, S., Brown, M., De Caprio, J.A., Cannistra, S.A., Feunteun, J., Schnitt, S., and Livingston, D.M. (1996). Location of BRCA1 in human breast and ovarian cancer cells. Science 272, 123-126.
24. Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., and Livingston, D.M. (1997a). Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265-275.
25. Scully, R., Anderson, S.F., Chao, D.M., Wei, W., Ye, L., Young, R.A., Livingston, D.M., and Parvin, J.D. (1997b). BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA 94, 5605-5610.
26. Scully, R., Chen, J., Ochs, R.L., Keegan, K., Hoekstra, M., Feunteun, J., and Livingston, D.M. (1997c). Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90, 425-435.
27. Shao, N., Chai, Y.L., Shyam, E., Reddy, P., and Rao, V.N. (1996). Induction of apoptosis by the tumor suppressor protein BRCA1. Oncogene 13, 1-7.
28. Sharan, S.K., Morimatsu, M., Albrecht, U., Lim, D.S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P., and Bradley, A. (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804-810.
29. Shen, S.X., Weaver, Z., Xu, X., Li, C., Weinstein, M., Chen, L., Guan, X.Y., Ried, T., and Deng, C.X. (1998). A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17, 3115-3124.
30. Smith, P.J. (1984). Relationship between a chromatin anomaly in ataxia-telangiectasia cells and enhanced sensitivity to DNA damage. Carcinogenesis 5, 1345-1350.
31. Socolovsky, M., Dusanter-Fourt, I., and Lodish, H.F. (1997). The prolactin receptor and severely truncated erythropoietin receptors support differentiation of erythroid progenitors. J. Biol. Chem. 272, 14009-14012.
32. -/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell 98, 181-191.
33. Somasundaram, K., Zhang, H., Zeng, Y.X., Houvras, Y., Peng, Y., et al. (1997). Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389, 187-190.
34. Tomlinson, G.E., Chen, T.T., Stastny, V.A., Virmani, A.K., Spillman, M.A., et al. (1998). Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res. 58, 3237-3242.
35. Weber, B.L. (1998). Update on breast cancer susceptibility genes. Recent Results Cancer Res. 152, 49-59.
36. Wilson, C.A., Payton, M.N., Elliott, G.S., Buaas, F.W., Cajulis, E.E., et al. (1997). Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. Oncogene 14, 1-16.
37. Wu, L.C., Wang, Z.W., Tsan, J.T., Spillman, M.A., Phung, A., et al. (1996). Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 14, 430-440.
38. Xu, X., Weaver, Z., Linke, S.P., Li, C., Gotay, J., Wang, X.W., Harris, C.C., Ried, T., and Deng, C.X. (1999a). Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389-395.
39. Xu, X., Wagner, K.U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A., and Deng, C.X. (1999b). Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat. Genet. 22, 37-43.
40. Yu, X., Wu, L.C., Bowcock, A.M., Aronheim, A., and Baer, R. (1998). The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273, 25388-25392.
41. Zhong, Q., Chen, C.F., Li, S., Chen, Y., Wang, C.C., Xiao, J., Chen, P.L., Sharp, Z.D., and Lee, W.H. (1999). Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285, 747-750.